Friday, October 2, 2026

BTC $84,503 ▼ 0.02%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

BTC$84,503−0.02%ETH$2,665−1.01%SOL$118.16+0.46%XRP$1.48−0.99%LINK$13.68−3.99%ADA$0.241−1.88%S&P 5007,723+0.73%Nasdaq27,191+1.19%Dow51,177+0.49%RUT2,833+0.94%TNX5.28%+0.76%TYX5.63%+0.48%FVX5.05%+1.00%IRX3.99%+0.28%VIX15.31−6.59%GOLD$4,172.10−0.72%SILVER$60.71−0.76%OIL$91.26−1.73%DXY101.92−0.17%NVDA$233.95+1.34%AAPL$333.69+1.02%TSLA$370.59+4.65%META$728.08+0.30%MSFT$517.53+0.92%AMZN$251.52+1.33%GOOGL$343.50+1.56%Fear & Greed72 — GreedBTC$84,503−0.02%ETH$2,665−1.01%SOL$118.16+0.46%XRP$1.48−0.99%LINK$13.68−3.99%ADA$0.241−1.88%S&P 5007,723+0.73%Nasdaq27,191+1.19%Dow51,177+0.49%RUT2,833+0.94%TNX5.28%+0.76%TYX5.63%+0.48%FVX5.05%+1.00%IRX3.99%+0.28%VIX15.31−6.59%GOLD$4,172.10−0.72%SILVER$60.71−0.76%OIL$91.26−1.73%DXY101.92−0.17%NVDA$233.95+1.34%AAPL$333.69+1.02%TSLA$370.59+4.65%META$728.08+0.30%MSFT$517.53+0.92%AMZN$251.52+1.33%GOOGL$343.50+1.56%Fear & Greed72 — Greed

Tag

melanoma vaccine

1 article

U.S. Equities40d ago

Moderna Surges 177% on Melanoma Vaccine Win; Wall Street Raises Targets

Moderna stock soared on positive Phase 3 results for its personalized melanoma vaccine with Merck, prompting Morgan Stanley to raise its price target to $89 from $39.